Page 69 - JCTR-11-4
P. 69

Journal of Clinical and
            Translational Research                                             AR-TAVR coaxiality assessment using 3DP



               systolic function. Circulation. 1991;84(4):1625-1635.  outcomes  after transcatheter  aortic valve  implantation  in
                                                                  high-risk patients with severe aortic stenosis: The U.K. TAVI
               doi: 10.1161/01.cir.84.4.1625
                                                                  (United Kingdom transcatheter aortic valve implantation)
            20.  Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR,   registry. J Am Coll Cardiol. 2011;58(20):2130-2138.
               Seward  JB, Tajik  AJ. Mortality  and  morbidity of  aortic
               regurgitation in  clinical practice. A  long-term  follow-up      doi: 10.1016/j.jacc.2011.08.050
               study. Circulation. 1999;99(14):1851-1857.      27.  Claessen BE, Tang GHL, Kini AS, Sharma SK. Considerations
               doi: 10.1161/01.cir.99.14.1851                     for optimal device selection in transcatheter aortic valve
                                                                  replacement: A review. JAMA Cardiol. 2021;6(1):102-112.
            21.  Babaliaros  V,  Cribier  A.  The  expansion  of  transcatheter
               technology  to  treat  aortic  insufficiency:  Everything      doi: 10.1001/jamacardio.2020.3682
               old becomes new again.  JACC  Cardiovasc  Interv.   28.  Silaschi M, Conradi L, Wendler O,  et al. The JUPITER
               2014;7(10):1175-1176.                              registry: One-year outcomes of transapical aortic valve
               doi: 10.1016/j.jcin.2014.07.005                    implantation using a second generation transcatheter heart
                                                                  valve for aortic regurgitation.  Catheter Cardiovasc Interv.
            22.  Rawasia WF, Khan MS, Usman MS, et al. Safety and efficacy   2018;91(7):1345-1351.
               of transcatheter aortic valve replacement for native aortic
               valve regurgitation: A systematic review and meta-analysis.      doi: 10.1002/ccd.27370
               Catheter Cardiovasc Interv. 2019;93(2):345-353.  29.  Markham R, Ghodsian M, Sharma R. TAVR in patients
               doi: 10.1002/ccd.27840                             with pure aortic regurgitation: Ready to use? Curr Cardiol
                                                                  Rep. 2020;22(9):98.
            23.  Fitzgerald S, Dumpies O, Shibata M, et al. Femoral arterial
               calcification and plug-  vs. Suture-based closure device      doi: 10.1007/s11886-020-01338-6
               strategies post-transcatheter aortic valve implantation:   30.  Medranda  GA,  Musallam  A,  Zhang  C,  et al.  The  impact
               Insights  from  CHOICE-CLOSURE.  Struct  Heart.    of aortic angulation on contemporary transcatheter aortic
               2023;8(2):100236.                                  valve replacement outcomes.  JACC Cardiovasc Interv.
               doi: 10.1016/j.shj.2023.100236                     2021;14(11):1209-1215.
            24.  Yoon SH, Schmidt T, Bleiziffer S, et al. Transcatheter aortic      doi: 10.1016/j.jcin.2021.03.027
               valve replacement in pure native aortic valve regurgitation.   31.  Wang DD, Qian Z, Vukicevic M,  et al. 3D printing,
               J Am Coll Cardiol. 2017;70(22):2752-2763.          computational modeling, and artificial intelligence
               doi: 10.1016/j.jacc.2017.10.006                    for structural heart disease.  JACC Cardiovasc Imaging.
                                                                  2021;14(1):41-60.
            25.  Genereux P, Head SJ, Hahn R, et al. Paravalvular leak after
               transcatheter aortic valve replacement: The new Achilles’      doi: 10.1016/j.jcmg.2019.12.022
               heel? A comprehensive review of the literature. J Am Coll   32.  Alkhouli M, Sengupta PP.  3-Dimensional-printed models
               Cardiol. 2013;61(11):1125-1136.
                                                                  for TAVR planning: Why guess when you can see? JACC
               doi: 10.1016/j.jacc.2012.08.1039                   Cardiovasc Imaging. 2017;10(7):732-734.
            26.  Moat NE, Ludman P, De Belder MA,  et al. Long-term      doi: 10.1016/j.jcmg.2017.05.002



























            Volume 11 Issue 4 (2025)                        63                            doi: 10.36922/jctr.24.00084
   64   65   66   67   68   69   70   71   72   73   74